已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Adaptive versus conventional cardiac resynchronisation therapy in patients with heart failure (AdaptResponse): a global, prospective, randomised controlled trial

医学 左束支阻滞 心力衰竭 束支阻滞 心脏病学 射血分数 内科学 QRS波群 人口 心脏再同步化治疗 心脏传导阻滞 失代偿 心电图 环境卫生
作者
Bruce L. Wilkoff,Gerasimos Filippatos,Christophe Leclercq,Michael R. Gold,Ahmad Hersi,Kengo Kusano,Wilfried Müllens,G. Michael Felker,Charan Kantipudi,Mikhael F. El‐Chami,Vidal Essebag,Bertrand Pierre,François Philippon,Francisco Perez-Gil,Eugene Chung,Juan C. Sotomonte,Stanley Tung,Balbir Singh,Babak Bozorgnia,Satish Goel
出处
期刊:The Lancet [Elsevier BV]
卷期号:402 (10408): 1147-1157 被引量:42
标识
DOI:10.1016/s0140-6736(23)00912-1
摘要

Continuous automatic optimisation of cardiac resynchronisation therapy (CRT), stimulating only the left ventricle to fuse with intrinsic right bundle conduction (synchronised left ventricular stimulation), might offer better outcomes than conventional CRT in patients with heart failure, left bundle branch block, and normal atrioventricular conduction. This study aimed to compare clinical outcomes of adaptive CRT versus conventional CRT in patients with heart failure with intact atrioventricular conduction and left bundle branch block.This global, prospective, randomised controlled trial was done in 227 hospitals in 27 countries across Asia, Australia, Europe, and North America. Eligible patients were aged 18 years or older with class 2-4 heart failure, an ejection fraction of 35% or less, left bundle branch block with QRS duration of 140 ms or more (male patients) or 130 ms or more (female patients), and a baseline PR interval 200 ms or less. Patients were randomly assigned (1:1) via block permutation to adaptive CRT (an algorithm providing synchronised left ventricular stimulation) or conventional biventricular CRT using a device programmer. All patients received device programming but were masked until procedures were completed. Site staff were not masked to group assignment. The primary outcome was a composite of all-cause death or intervention for heart failure decompensation and was assessed in the intention-to-treat population. Safety events were collected and reported in the intention-to-treat population. This study is registered with ClinicalTrials.gov, NCT02205359, and is closed to accrual.Between Aug 5, 2014, and Jan 31, 2019, of 3797 patients enrolled, 3617 (95·3%) were randomly assigned (1810 to adaptive CRT and 1807 to conventional CRT). The futility boundary was crossed at the third interim analysis on June 23, 2022, when the decision was made to stop the trial early. 1568 (43·4%) of 3617 patients were female and 2049 (56·6%) were male. Median follow-up was 59·0 months (IQR 45-72). A primary outcome event occurred in 430 of 1810 patients (Kaplan-Meier occurrence rate 23·5% [95% CI 21·3-25·5] at 60 months) in the adaptive CRT group and in 470 of 1807 patients (25·7% [23·5-27·8] at 60 months) in the conventional CRT group (hazard ratio 0·89, 95% CI 0·78-1·01; p=0·077). System-related adverse events were reported in 452 (25·0%) of 1810 patients in the adaptive CRT group and 440 (24·3%) of 1807 patients in the conventional CRT group.Compared with conventional CRT, adaptive CRT did not significantly reduce the incidence of all-cause death or intervention for heart failure decompensation in the included population of patients with heart failure, left bundle branch block, and intact AV conduction. Death and heart failure decompensation rates were low with both CRT therapies, suggesting a greater response to CRT occurred in this population than in patients in previous trials.Medtronic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
芯之痕发布了新的文献求助10
刚刚
研友_VZG7GZ应助顺利秋灵采纳,获得10
刚刚
徐小树发布了新的文献求助10
1秒前
坚定的凝云完成签到 ,获得积分10
2秒前
3秒前
bkagyin应助zhantianao采纳,获得10
5秒前
徐志豪完成签到,获得积分10
5秒前
wanci应助科研通管家采纳,获得10
5秒前
SciGPT应助科研通管家采纳,获得10
5秒前
科研通AI5应助科研通管家采纳,获得10
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
Hayat应助科研通管家采纳,获得10
5秒前
fly发布了新的文献求助10
7秒前
爱听歌凤灵完成签到 ,获得积分10
8秒前
lxl98完成签到 ,获得积分10
9秒前
10秒前
lwh104完成签到,获得积分10
11秒前
12秒前
13秒前
顺利秋灵发布了新的文献求助10
15秒前
漂亮白枫发布了新的文献求助10
15秒前
dzk完成签到,获得积分10
16秒前
asdfghjkl完成签到,获得积分20
16秒前
番茄黄瓜芝士片完成签到 ,获得积分10
16秒前
风趣的老太应助YDX采纳,获得10
19秒前
凌七发布了新的文献求助10
20秒前
王旭东完成签到 ,获得积分10
21秒前
犹豫的夏旋完成签到 ,获得积分10
21秒前
BBH完成签到,获得积分10
22秒前
Lee发布了新的文献求助10
22秒前
禾苗完成签到 ,获得积分10
25秒前
26秒前
林洁佳完成签到,获得积分10
28秒前
淡然平蓝完成签到 ,获得积分10
32秒前
西瓜刀完成签到 ,获得积分10
32秒前
领导范儿应助BBH采纳,获得10
32秒前
凌七完成签到,获得积分10
34秒前
bkagyin应助漂亮白枫采纳,获得10
39秒前
野猪大王完成签到 ,获得积分10
40秒前
咚咚完成签到 ,获得积分10
42秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976583
求助须知:如何正确求助?哪些是违规求助? 3520659
关于积分的说明 11204399
捐赠科研通 3257298
什么是DOI,文献DOI怎么找? 1798683
邀请新用户注册赠送积分活动 877842
科研通“疑难数据库(出版商)”最低求助积分说明 806595